← Leaderboards
Cheryl H Waters
University Of Southern California
$347,081
Attributed
$347,081
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$347,081 · 1
By mechanism
M01$347,081 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Caryn Lerman$95,133,528
- Arthur W Toga$135,966,223
- Heinz Josef Lenz$20,123,312
- Thomas A Buchanan$121,360,154
- Donald B Kohn$24,055,774
Others in their field
Top investigators on “Antiparkinson Drugs”
- P Jeffrey Conn · Vanderbilt University$4,333,958
- Maryka Quik · Parkinson'S Institute$3,960,055
- Stanley Fahn · Columbia University Health Sciences$3,010,901
- Marc G. Caron · Duke University$2,577,387
- Thomas N. Wichmann · Emory University$2,326,392
- Un Jung Kang · University Of Chicago$1,837,499
Research focus
Antiparkinson DrugsBrain Disorder ChemotherapyClinical ResearchHuman SubjectHuman Therapy EvaluationParkinson'S DiseasePharmacokinetics
Grant awards (5)
PNU 95666E IN PATIENTS W/ PARKINSONS DISEASE$0
M01 · FY2002 · RR
PNU 95666E IN PATIENTS W/ PARKINSONS DISEASE$155,764
M01 · FY2001 · RR
PNU 95666E IN PATIENTS W/ PARKINSONS DISEASE$0
M01 · FY2001 · RR
PNU 95666E IN PATIENTS W/ PARKINSONS DISEASE$155,764
M01 · FY2000 · RR
PNU 95666E IN PATIENTS W/ PARKINSONS DISEASE$35,553
M01 · FY2000 · RR